Satellite Symposia
The Satellite Symposia are industry-sponsored, CME-certified programs offered in conjunction with ASH specialty meetings. These events are offered in conjunction with the 2023 Highlights of ASH in North America and are not part of the official ASH meeting programming and are planned solely by the sponsoring company. There is no fee to attend and registration to HOA is not required to participate.
The 2023 Satellite Symposia were presented once, live at the date, time, and location listed. If the managing company shared post-program content with ASH, it will be listed below the session. For program-specific questions, please reach out to the managing company contact listed below each session.
ASH appreciates its corporate and nonprofit partners for their participation in Satellite Symposia. The Society values its partnerships and the supportive role that members of this community play to provide hematologists with quality educations programs. The deadline for applications has passed.
Washington, DC
Keeping Pace with Rapid Advancements in Multiple Myeloma Care
Friday, January 13, 2023, at 6:00 – 8:00 p.m.
Omni Shoreham Hotel, 2500 Calvert Street, NW, Washington, DC, in Hampton Room (Level 1)
This symposium is CME-certified and will be presented LIVE at the date, time, and location above.
This program is supported by Sanofi.
This satellite symposium is designed to provide an update to the hematology/ oncology community, especially those practitioners who did not have the opportunity to attend the ASH Annual Meeting in December. This activity will be steered by leading experts in the multiple myeloma field who will illustrate how to properly apply recent clinical data as practical strategies in a real-world setting. The experience will allow practitioners to keep pace with the evolving treatment landscape and better inform their healthcare team and patients of the latest treatments and select from available options, including those in a clinical trial.
Managing Company: Physicians’ Education Resource, LLC
Symposium Contact: James Palatine at [email protected]
Seattle, WA
Oncology Roundtable™: Treating MF and PV in 2023
Friday, January 13, 2023, at 6:00 – 8:00 p.m.
Fairmont Olympic Hotel, 411 University Street, Seattle, WA, in the Congress Room
This symposium is CME-certified and will be presented LIVE at the date, time, and location above.
This program is supported by CTI Biopharma, Inc., and PharmaEssentia USA Corporation
This satellite symposium is designed to provide an update to the hematology/ oncology community, especially those practitioners who did not have the opportunity to attend the ASH Annual Meeting in December. This activity will be steered by leading experts in the multiple myeloma field who will illustrate how to properly apply recent clinical data as practical strategies in a real-world setting. The experience will allow practitioners to keep pace with the evolving treatment landscape and better inform their healthcare team and patients of the latest treatments and select from available options, including those in a clinical trial.
Managing Company: Physicians’ Education Resource, LLC
Symposium Contact: James Palatine at [email protected]
Chicago, IL
Equalizing Inequities in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes
Friday, January 20, 2023, at 6:00 – 8:00 p.m.
Fairmont Chicago, Millennium Park, 200 N Columbus Drive, Chicago, IL in State Room (2nd Floor)
This symposium is CME-certified and will be presented LIVE at the date, time, and location above.
This program is supported by Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and Sanofi.
During this program, key opinion leaders in multiple myeloma will lead a structured discussion of multiple myeloma incidence, risk, and pathophysiology among different racial populations, as well as barriers to optimal management and disparities in clinical trials and drug development. Future directions in the field will also be addressed and considered in the context of how these barriers can be overcome in the community, beginning with increased awareness and research. This discussion is designed to be an open exchange of ideas and opinions among leading researchers in the field of racial disparities in myeloma care. Relevant clinical trial results and research data may be presented to support these discussions.
This program has concluded. For program-specific questions, please reach out to the managing company contact below.
Managing Company: Physicians' Education Resource, LLC
Symposium Contact: James Palatine at [email protected]
New York, NY
Fine-Tuning the Wave of Innovation in CLL: Personalized Models for Upfront and Sequential Care with Groundbreaking Treatment
Friday, January 20, 2023, at 6:00 – 8:00 p.m.
Conrad New York, 102 North End Avenue, New York, NY in West Ballroom, Second Floor.
This symposium is CME-certified and will be presented LIVE at the date, time, and location above.
This program is supported by AbbVie, AstraZeneca, BeiGene, Bristol Myers Squibb, Lilly, Merck & Co., Inc., and Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
PeerView’s unique “Seminars & Tumor Board” live event, incorporating the latest data from the 64th ASH Annual Meeting and Exposition, will convene a panel of leading CLL experts who, mimicking the collaborative nature of real-world tumor boards, will blend serial, case-based discussion with mini seminars designed to illustrate how integrating targeted therapeutics—including second-generation and non-covalent BTK inhibitors, time-limited BCL-2 inhibitor options, as well as novel combinations—can improve care across the spectrum of CLL. Each session will cover important clinical topics such as the personalized, evidence-based selection of upfront treatment strategies, therapeutic sequencing in progressive disease settings, safety management and distinctions among agent classes, the use of MRD assessment as a treatment tool, and next-generation and novel combinatorial strategies. Join us for this exciting case-based event in January!
This program has concluded. For program-specific questions, please reach out to the managing company contact listed below.
Managing Company: PeerView Institute for Medical Education
Symposium Contact: Christine Bloom at [email protected]
San Francisco, CA
Keeping Pace with Rapid Advancements in Multiple Myeloma Care
Friday, January 27, 2023, at 6:00 – 8:00 p.m.
Parc 55 San Francisco, 55 Cyril Magnin Street, San Francisco, CA in Embarcadero Room (Level 3)
This symposium is CME-certified and will be presented LIVE at the date, time, and location above.
This program is supported by Sanofi.
This satellite symposium is designed to provide an update to the hematology/ oncology community, especially those practitioners who did not have the opportunity to attend the ASH Annual Meeting in December. This activity will be steered by leading experts in the multiple myeloma field who will illustrate how to properly apply recent clinical data as practical strategies in a real-world setting. The experience will allow practitioners to keep pace with the evolving treatment landscape and better inform their healthcare team and patients of the latest treatments and select from available options, including those in a clinical trial.
This program has concluded. For program-specific questions, please reach out to the managing company contact listed below.
Managing Company: Physicians' Education Resource, LLC
Symposium Contact: James Palatine at [email protected]
Questions?
Please contact Kelly Cade, ASH Grants and Satellite Symposia Manager, Consultant, at [email protected].
Satellite Symposia Program Details
The Satellite Symposia are industry-sponsored, CME-certified programs offered in conjunction with ASH specialty meetings. These events are not part of the official ASH meeting programming and are planned solely by the sponsoring company.
Application Requirements
Satellite Symposia should be unique and answer an unmet educational need. The program details and application deadlines for the upcoming Satellite Symposia will be available soon. Satellite Symposia applications and proposals must be submitted online.
Please pay close attention to each required component of the application, as incomplete applications will not be reviewed. All information submitted along with the application will be considered final, and no changes may be made once submitted. This includes, but is not limited to, change in the management company, CME provider, corporate supporter, speakers, symposium topics, and program title.
Please be as accurate and detailed as possible, as ASH will provide this information to all registered and potential attendees through the meeting’s program.
Applications must be signed by representatives accepting responsibility for the program. By signing the application, each representative agrees to take responsibility for following ASH guidelines for the Satellite Symposia. Please designate one contact person with whom ASH should communicate and who agrees to share information with other representatives.
Satellite Symposia Opportunities
ASH will accept up to two (2) applications from one company as a sole supporter of a symposium. ASH does not limit the number of applications of co-supported symposia. That is, so long as there are multiple supporting companies on a symposium proposal, there is no limit to the number of applications that may be submitted to ASH for consideration.
All Opportunities - $13,500
- ASH will limit the number of symposia programs offered to one symposium per meeting location (for a total of five), held from 6:00 – 8:00 p.m. in the meeting location’s time zone on Friday.
Please note, the study section score will determine which symposia are selected. All applications received prior to the deadline of November 28, 2022, at 11:59 p.m. Pacific time will be reviewed and scored at the same time regardless of the order received.
Satellite Symposia Fees
A flat rate of $13,500 will be applicable for each Satellite Symposia program.
Payment must be made to the American Society of Hematology, and funding must be confirmed at the time of submission. Applicants are required to submit a funding commitment letter from all supporting companies for each company to be listed as a co-supporter in promotional materials.
Additional fees may apply for special requests. If you have questions, please contact Kelly Cade, ASH FSS Manager, Consultant, at [email protected].
CME Accreditation
All Satellite Symposia programs must provide CME credit; organizers are responsible for obtaining the proper accreditation.
Only organizations accredited by the Accreditation Council for Continuing Medical Education (ACCME) may sponsor CME activities and may award AMA PRA Category 1 CreditTM. These accredited providers are responsible for the content, quality, and scientific integrity of all CME activities certified for credit.
ASH does not suggest or approve content or speakers for activities for which it is not the accredited provider. ASH encourages all providers participating in the Satellite Symposia to review the current ACCME Standards for Commercial Support. These standards, along with tools to implement them, can be found at www.accme.org.
- Speakers must disclose relevant conflicts of interest prior to the CME activity. A written disclosure slide must precede each presentation.
- Speakers must provide appropriate disclosures of non-FDA approved (off-label) uses for drugs and medical devices.
- References must be included with data and slides.
- There must be appropriate evaluation of symposium content and speakers as well as a final attendance count. Please email the evaluation summary [email protected]. no later than 30 days after the program has ended.
Program Content
The proposed program content must be unique and must offer the audience information not previously presented during other forums or meetings within the hematology/oncology community.
- The proposed program title must be indicative of the symposium content.
- The proposed objectives should clearly meet the educational needs of the target audience.
- The program must be presented in an objective, balanced, and scientifically rigorous manner. The program cannot promote a specific drug product or service and must meet the policies and guidelines of ACCME.
- The content and format of the CME activity and its related materials must promote improvements or quality in health care and not a specific proprietary business interest.
Speakers
Program Speakers at the programs listed below are strictly prohibited from participating in Satellite Symposia. Disclosure information for each speaker must be submitted to ASH with the application. There are no exceptions.
ASH asks that the letters of invitation to the symposium speakers indicate ASH’s expectation that speakers will not substitute participation in a Satellite Symposia for participation in ASH’s Education or Scientific Committee sessions.
Scoring Process
Applications will be scored based on the information you provide. All relevant information should be included in the written application.
A formal study section will score applications based on the quality of the proposal. The group will be looking for scientific merit, audience interest in the topic, and uniqueness of the symposium. The study section’s scores are confidential, and the decision is final with no opportunity for appeal.
After the study section scores the applications, ASH will email each contact person listed on the application. The contact person for each approved symposium will also receive detailed instructions about logistics, as well as an invoice and letter of agreement.
The study section score will determine which symposia are selected. All applications received prior to the deadline of November 28, 2022, at 11:59 p.m. Pacific time will be reviewed and scored at the same time regardless of the order received.
Please note: Applicants for the Satellite Symposia may not contact the study section, ASH members, or the ASH Executive Committee to influence the selection(s) for the Satellite Symposia presentations. No recommendations and/or letters of support will be accepted for any application.
Educational Materials
A one-page evaluation summary report, including a final attendance count, must be sent to Kelly Cade, ASH FSS Manager, Consultant, at [email protected] by the deadline outlined in the Important Dates and Deadline below.
Please keep in mind that CME enduring materials are different from syllabus materials or other printed (or electronic) records of the symposium. Enduring materials are printed, recorded, or computer-assisted educational materials that may be used over time at various locations and that in and of themselves constitute a planned CME activity. An enduring material, as a self-contained educational activity, must have its own needs assessment, educational objectives, content, evaluation instrument, and opportunity for physician learner interaction and discussion.
As a separate educational activity, an enduring material must also have its own CME credit separate from the Satellite Symposia accreditation (i.e., if an Satellite Symposia organizer obtains CME credit for the symposium, the credit for the symposium does not translate or cross over to any enduring materials produced from content presented at the symposium).
Promotion of Satellite Symposia
ASH must review and approve all promotional materials created by symposia organizers in conjunction with the Satellite Symposia, including invitations, announcements, fliers, websites, and signs. Please allow up to five business days for ASH to consider requests for approval.
For specific deadlines on submitting promotional and educational materials for approval by ASH, please review the Important Dates and Deadlines below.
All companies hosting a Satellite Symposium must abide by the following:
- The ASH logo (or a graphic designed to mimic the ASH logo) may not be used on any promotion or other materials (including enduring materials) produced by companies other than ASH.
- Use of the American Society of Hematology’s name or copyrighted material on any announcement, sign, publication, or other material requires prior written approval by ASH. To request approval, email [email protected].
- Because Satellite Symposia are not officially part of any ASH meeting, companies cannot reference their symposia as part of the official ASH meeting or imply that they are ASH events. It is acceptable to refer to the event as a "Satellite Symposium on [title], following the adjournment of the first day of the [ASH meeting]."
Signage
All symposium signage must conform to the following specifications:
- One (1) 38”x87” meter panel, poster, or banner with affixed box of program handouts or projection is permitted directly outside of the symposium room.
- One (1) 22”x28” directional sign is permitted at hotel-approved locations.
- One (1) 22"x28" directional sign permitted at the exit of the MHM session rooms 30 minutes prior to program close.
- No additional signage will be allowed. Any additional signage found will be removed and discarded by ASH.
Companies are not permitted to post promotional signs or literature in hotel lobbies. Sandwich boards and/or persons handing out promotional materials are prohibited. Standing in the public areas of the hotel lobby and hallway to promote your symposium is strictly prohibited. This will be closely monitored, and companies found violating these guidelines risk penalties from ASH. Management companies handling logistics are responsible for following these guidelines as well.
Please note, the Satellite Symposia organizer is ultimately responsible for marketing and promoting Satellite Symposia programming. As a promotional benefit to the companies hosting a Satellite Symposia, ASH will provide the following:
- The pre-registration attendee list will also be available for purchase. For mailing list inquiries and orders, please contact Kelly Cade at [email protected].
- A listing of each symposium, including narrative description, location, contact information, and registration and program related hyperlinks placed on the ASH website and on the meeting platform.
- Three email blasts to registered attendees, which will list the Satellite Symposia title, time, and location. E-blast schedule will be listed closer to ASH meeting dates.
In addition, the pre-registration attendee mailing list will be available for purchase for $1,000. ASH pre-approval of all mailing pieces is required. Sample mail pieces must be emailed along with the mailing request form to Kelly Cade, ASH Grants and Satellite Symposia Manager, Consultant, at [email protected]. Please review the Important Dates and Deadlines below.
Satellite Symposia Program Requirements
Program requirements include:
- ASH meeting registration is not a requirement for admittance to Satellite Symposia. Please note, the organizer is ultimately responsible for marketing and promoting programming.
- ASH requires that on-site registration (outside the symposium room) be limited to one six-foot table.
- The room will be set to accommodate the space capacity. Any requested changes to the room set must be arranged directly with the hotel.
- Symposium presentations must be contained within your assigned room. Video overflow to adjacent rooms will not be permitted.
- Registration and food functions may not begin prior to or be held after the assigned time frame.
Audio/Visual
The Satellite Symposia organizer is responsible for arranging their audio-visual needs directly with the hotel’s in-house provider or via a hotel-approved third-party vendor. It is the organizer’s responsibility to confirm any/all outside vendors directly with the hotel.
Priority Points
Every partnership is important to ASH. In exchange for your company’s support, ASH ensures appropriate acknowledgment of all contributions and assigns exhibitor priority points according to the scale below. The combination of three years of support make up your company’s ranking. Specifically, the annual meeting ranking will be determined by points accumulated in 2021, 2022, and 2023. The ranking determines future exhibit booth placement and group housing block placement for the ASH Annual Meeting and Exposition.
- You will receive one priority point for every $2,500 by supporting a symposium.
Penalties for Violating ASH Policies
Violation of ASH policies will result in the following penalties:
- Priority points will be reduced.
- The company may not be eligible for participation in future Satellite Symposia.
- The company may not have access to ancillary meeting space in future years.
- The company may not participate as an exhibitor in future years.
Cancellation Policy
All Satellite Symposia cancellations must be submitted to in writing to [email protected].
- Any cancellation requests received on or after Friday, December 5, 2022, will incur a 100 percent cancellation penalty. The Satellite Symposia host will be issued no refund of any monies received by ASH for cancellation.
Cancellation of Meeting
It is mutually agreed that in the event of cancellation of this meeting as a result of strikes, acts of God, war, terrorism, disaster, government regulations or other causes that prevent its scheduled opening or continuance, this agreement will be terminated immediately. ASH shall determine an equitable basis for refund of a portion of the Satellite Symposia fee as possible, after due consideration of expenditures and commitments already made.
Important Dates and Deadlines
Monday, November 28, 2022
- Deadline for Satellite Symposia application submissions by 11:59 p.m. Pacific time
Thursday, December 1, 2022
- Acceptance letters emailed to accepted program organizer(s)
- Following acceptance, please submit registration site links to ASH to post on the website at your earliest convenience to [email protected]
Friday, December 5, 2022
- Satellite Symposia signed letter of agreements due to ASH to [email protected]
- Any cancellation requests received on or after Friday, December 5, 2022, will incur a 100 percent cancellation penalty.
Monday, December 12, 2022
- Payments are due
- Submission deadline for approval by ASH of promotional and education materials (invitations, eblasts, ads, etc.) to [email protected]
Monday, February, 27 2023
- Copy of the one-page summary evaluation and final attendance count must be submitted to [email protected] by COB Pacific Time